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Abstract
The FCGR3 locus encoding the low affinity activating receptor FcγRIII, plays a vital role in
immunity triggered by cellular effector and regulatory functions. Copy number of the genes
FCGR3A and FCGR3B has previously been reported to affect susceptibility to several auto-
immune diseases and chronic inflammatory conditions. However, such genetic association
studies often yield inconsistent results; hence require assays that are robust with low error
rate. We investigated the accuracy and efficiency in estimating FCGR3 CNV by comparing
SequenomMassARRAY and paralogue ratio test-restriction enzyme digest variant ratio
(PRT-REDVR). In addition, since many genetic association studies of FCGR3B CNV were
carried out using real-time quantitative PCR, we have also included the evaluation of that
method’s performance in estimating the multi-allelic CNV of FCGR3B. The qPCR assay ex-
hibited a considerably broader distribution of signal intensity, potentially introducing error in
estimation of copy number and higher false positive rates. Both Sequenom and
PRT-REDVR showed lesser systematic bias, but Sequenom skewed towards copy number
normal (CN = 2). The discrepancy between Sequenom and PRT-REDVR might be attribut-
ed either to batch effects noise in individual measurements. Our study suggests that
PRT-REDVR is more robust and accurate in genotyping the CNV of FCGR3, but highlights
the needs of multiple independent assays for extensive validation when performing a genet-
ic association study with multi-allelic CNVs.
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Introduction
Copy number variation (CNV) is defined as genetic variation involving a loss or gain of large
segments of DNA (typically over 1 kb), a definition that includes simple deletions and duplica-
tions [1]. CNV can affect phenotype by altering gene dosage, disrupting coding sequences, or
perturbing long-range gene regulation [2], and has been associated with susceptibility to vari-
ous autoimmune and infectious diseases [3–7].
Fcγ receptors function as cell surface receptors for the Fc region of IgG, are found on the
surface of natural killer cells, monocytes, neutrophils, and mast cells, and play a critical role in
immunity. In humans, there are three main types of Fcγ receptors, high-affinity FcγRI and low
affinity FcγRII and FcγRIII [8]. They bind to IgG-antigen immune complex and initiate either
inhibitory or activating responses within the cell [9]. FcγRII receptors are encoded by
FCGR2A, 2B, 2C and FcγRIII receptors are encoded by FCGR3A and FCGR3B respectively, and
these genes are located as a cluster at 1q23.3. FCGR3A and FCGR3B encode FcγRIIIA and
FcγRIIIB respectively, which are different from each other both in their attachment to the cell
surface and in their expression pattern: FcγRIIIA has a transmembrane region and is expressed
on natural killer cells, and FcγRIIIB is attached to the cell membrane by a glycophosphoinositol
anchor and is expressed primarily on neutrophils [10]. FCGR3A and FCGR3B are paralogous
genes each on an 82 kb segmental duplication which is ~98% identical at the DNA level.
FCGR3B carries the two common alleles of the human neutrophil antigen HNA1 that differ by
four amino acid substitutions: HNA1a and HNA1b [11]. Recurrent non-allelic homologous re-
combination between the two segmental duplications generates CNV within populations af-
fecting both FCGR3A and FCGR3B [12–14].
The CNV of FCGR3B has been reported to be associated with susceptibility to a number of
autoimmune diseases including systemic lupus erythematosus (SLE), organ-specific autoim-
munity, and rheumatoid arthritis [14–16]. However, genetic association studies for multi-
allelic CNV remains problematic as spurious copy number calls could lead to false association
thus yield inconsistent replications [17–19]. This is predominantly due to lack of robust and
accurate methods in assaying such genetic variation. Therefore in this paper, we compare three
typing assays: paralogue ratio test-restriction enzyme digest variant ratio (PRT-REDVR) [13],
real-time qPCR [16] and Sequenom MassARRAY (Sequenom Inc. Brisbane, Australia).
Materials and Methods
Ethical approval and subject recruitment
This study obtained approval from the Research and Ethics Committee of Universiti Teknologi
MARA (UiTM) [600-RMI (5/1/6)], Universiti Sains Malaysia (USM) [USMKK/PPP/JePeM
[211.3.(6)] and the Ministry of Health [NMRR-09–1128–4211]. Informed and written consent
were obtained from the individuals for the study of host genetic susceptibility to dengue fever.
A total of 237 dengue patients were recruited from Hospital Kota Bharu (HKB) and Hospital
USM. A total of 3 ml peripheral blood was collected for each recruited individual.
DNA extraction
The QiaAMP Blood Mini Kit (Qiagen, Germany) was used to extract DNA from 200 μl of pe-
ripheral blood sample according to the manufacturer’s protocol. Concentration and purity of
the extracted DNA were determined by spectrophotometer Nanodrop ND-1000. The quality
of DNA was confirmed by electrophoresis on a 1% agarose gel, followed by SyBr safe staining
to ensure that the DNA samples were not degraded based on the clear single band generated.
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Real-time quantitative PCR (qPCR)
The primer sequences for the target gene FCGR3B and the reference gene FOXP2 were ob-
tained from Fanciulli et al. [16]. A total of 5 μl (10 ng/µl) genomic DNA was amplified in a re-
action mixture containing 12.5 μl iQ SyBr Green Supermix (BioRad), 1 μl (7 μM/μl) of each of
forward and reverse primers, and made up to total volume of 25 μl with ddH2O. Cycling condi-
tions were 95˚C for 3 min, and then 40 cycles of 95˚C for 30 s, followed by 60˚C for 15 s and
72˚C for 30 s. The FCGR3B primer sequences were: Forward: 50-CACCTTGAATCTCATCCC-
CAGGGTCTTG-30 and Reverse: 50-CCATCTCTGTCACCTGCCAG-30. The amplification
was carried out using BioRad CFX96 Touch Real-Time PCR Detection System.
The efficiency of the assay was determined by the generation of a standard curve: a series of
five-fold dilutions of a single genomic DNA sample from 50 ng/μl to 0.08 ng/μl (10 ng to 0.016
ng in each qPCR). All reactions were run in triplicate. For a high quality assay, amplification
should be linear across the entire dilution series with amplification efficiencies between
90–110%. Normalization to the control gene Forkhead Box P2 (FOXP2) (Forward: 50-TGA-
CATGCCAGCTTATCTGTTT-30 and Reverse: 50-GAGAAAAGCAATTTTCACAGTCC-30)
[16] was used to give an estimate of copy number. Copy number of the target sequence in each
test sample was determined by using the comparative CT (2-CT) approach. The relative copy
number of the target gene in each test sample in relation to the reference gene was determined
by relative quantification through the comparative CT (ΔΔCT) calculation method as previous-
ly mentioned by Livak and Schmittgen [20]. Assumption of exact doubling of the target se-
quence was made in this method. After normalisation to the median value of all samples in the
assay, which was assumed to represent a diploid copy number of 2, deletions of FCGR3B were
called for samples with a value<1.5, and duplications of FCGR3B were called for samples with
a value>2.6. These values were chosen based on clustering of raw copy number values of the
entire sample set.
SequenomMassARRAY genotyping
SequenomMassARRAY uses the primer extension approach for both relative, and absolute de-
termination of CNV calls [21]. For both FCGR3A and FCGR3B three assays were designed at
the 3-prime, 5-prime and centre of each gene, targeting a single nucleotide variant (SNV) that
distinguished the two paralogues [22] (Table 1). In effect, these SNV sites were being used for
paralogue-specific quantification, hence the relative signal from each paralogue was investigat-
ed. All test samples were assayed with one multiple primer master mix, and primer extension
PCR was performed. The extended products were analysed by SEQUENOMMALDI-TOF
mass spectrometry.
Table 1. Primer sequences and single nucleotide variation (SNV) identified for FCGR3A/B in Sequenom MassARRAY.
Primer Sequence SNV identified
3A 3B
FCRG3A/B—centre 50-ACGTTGGATGTGGTTGTAGGTGGACATCTC T C
30-ACGTTGGATGCTGACATGGTCTTCACTCTC
FCGR3A/B—30 50-ACGTTGGATGAGATATCCGGAGCCCTAAAG A A
30-ACGTTGGATGTGACAGAGATGGGTGGAGG
FCGR3A/B—50 50-ACGTTGGATGCAGTAGTACATTTAGTATTGG C T
3’-ACGTTGGATGAAAACCACCTTTTCTGCTTC
doi:10.1371/journal.pone.0116791.t001
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There are two steps in SequenomMassARRAY allowing the inference of genomic copy
number. The first stage relies on comparison of an amplicon for the region of interest with a
known amount of a competitor DNA amplicon of known genotype, using primer extension
and mass spectrometry to quantify the amount of each variant at a particular SNV. Compari-
son of the ratio of the genomic amplicon with the competitor DNA provides information
about the copy number of the region of interest. The second stage relies on a comparison of
the amount of amplicon for the region of interest and the amount of a control amplicon where
diploid copy number is assumed to be two, co-amplified from the same genomic DNA. Three
control regions were included in the study: i) chr11: 31,700,000–31,880,000; ii) chr6:
43,864,065–43,904,064; iii) chr7: 113,800,000–114,150,000, reference coordinates based on ge-
nome assembly build hg18. Approximately 100–120 bp of oligonucleotide sequence corre-
sponding to the control and test regions was synthesized and titrated by serial dilution to
optimise the iPLEX experiment (Sequenom) for equal peak sizes for the control regions and
test region. The 2N controls were used to normalize intra-assay sample to sample loading vari-
ation, and the CNV of interest against a normal control.
The details of analysis of copy number calls for MassARRAY are described in the Sequenom
Quickguide [21]. In brief, absolute copy number was calculated from the logEC50 value gener-
ated via the titration series in Sequenom QGE software provided by Sequenom Inc. The EC50
value is the point at which the peak areas of the test DNA and the competitor DNA are equal,
representing a 1:1 concentration of the molecules in the reaction (ratio 1:1). This point is de-
fined as the effective concentration required for obtaining 50% of the maximal effect (EC50).
Subsequently the absolute copy numbers obtained were further normalized as was done in the
qPCR mentioned earlier.
Paralogue Ratio Test (PRT)
The PRT-REDVR assays were carried out as described according to Hollox et al. [13]. Briefly
the amplification of 10 ng of DNA was performed in a final volume of 10 μl, with 0.5 μM for-
ward primer and 0.5 μM FAM- or HEX- labelled reverse primer, in a reaction buffer. The
primer sequences used are shown in Table 2. The two amplifications were carried out (with
FAM- or HEX- labelled primer respectively), to allow detection and co-electrophoresis of the
amplicons on the capillary electrophoresis. This allows internal calibration of each experiment.
Products were amplified using 30 cycles of: 95˚C for 30 s, 56˚C for 30 s and 70˚C for 30 s fol-
lowed by single chase of 56˚C for 1 min then 70˚C for 20 min to reduce levels of single-strand-
ed DNA products. After the PCR cycle, 1 µl of a 10% to 20% dilution of each PCR product was
added to 10 µl deionized formamide, and analysed by electrophoresis on an ABI 3100 Genetic
Analyzer (Applied Biosystems, Warrington, UK), with an injection time of 30 s.
The respective PCR amplicons sized 67 bp corresponding to chromosome 1, and 72 bp cor-
responding to chromosome 18, were recorded for both FAM- and HEX- labelled products. The
ratio of the areas under the 67 bp peak and the 72 bp peak was compared, and the results
were accepted if the coefficient of variation (standard deviation divided by the mean) was
<0.15. The mean of the FAM and HEX ratio was used in further analysis.
Table 2. Primer sequences for FCGR3 PRT assay.
Primer orientation Sequence
FCGR3B_Forward (HEX) 50-ATGATCTGGCCCTGAAACTC-30
FCGR3B_Forward (FAM) 50- ATGATCTGGCCCTGAAACTC -30
FCGR3B_Reverse 50-TGAGTTCAAGAAAGCAGTTG-30
doi:10.1371/journal.pone.0116791.t002
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Both the mean ratios and 9 reference standards with known copy numbers obtained from
Human Random Control DNA (European Collection of Cell Cultures) were used as the cali-
bration for each experiment, and the resulting linear regression was used to estimate the copy
number of FCGR3 for the samples studied, as described in [13].
Restriction Enzyme Digest Variant Ratio (REDVR)
Two REDVR assays were used in this study: one distinguishes variant from FCGR3A and
FCGR3B (c.733C>T, corresponding to the arginine to stop codon change that defines
FCGR3B) and the other distinguishes neutrophil antigens HNA1a and HNA1b (g.147C>T)
[13]. Amplification of two regions in duplex was carried out using primer sequences as shown
in Table 3 with concentration of 0.5 μM and the conditions described above, except with an an-
nealing temperature of 53˚C: 2 μl of PCR product was digested with 10 units of TaqαI restric-
tion enzyme (New England Biolabs) in 50 mM Tris-Cl (pH 7.9 at 25˚C), 100 mMNaCl, 10
mMMgCl2,1 mM dithiothreitol in a final volume of 10 μl for 4 hours at 65˚C. Digested prod-
ucts were analysed with capillary electrophoresis on an ABI 3100 Genetic Analyzer (Applied
Biosystems) and analysed with GeneScan software (Applied Biosystems). Mean ratios of the
product were used along with the reference standard for experimental calibration and the result
was used to estimates copy number calls.
The PRT analysis for copy number call was performed in combination with the REDVR
analysis, using a maximum likelihood approach described previously [13]. PRT produces the
sum of the copy number calls for FCGR3A and FCGR3B genes whilst the REDVR estimates the
copy numbers of FCGR3A and FCGR3B based on the ratio determined [13]. Analyses were per-
formed using Microsoft Excel unless otherwise stated.
Results and Discussion
We first assessed the distribution of the raw copy number calls for FCGR3A from Sequenom
(Fig. 1A). Distinct clustering was observed around the integers, indicating relatively high con-
sistency of this assay in FCGR3A. 81% (101/161) of the absolute copy number from Sequenom
were in agreement with PRT-REDVR, but the Sequenom data tended to be skewed towards a
diploid copy number of two (Fig. 1B; S1 Table). A higher rate of inconsistency between these
two assays was observed with higher copy number (Fig. 2).
Next, we analysed the copy number calls for FCGR3B with the sample genotyped with all
three assays namely, qPCR, Sequenom and PRT-REDVR (N = 80). In general, copy number
called by qPCR showed a greater variability (gains or losses) (Fig. 3), and relatively broader dis-
tribution compared to Sequenom (Fig. 4), suggesting lower specificity of qPCR, in line with the
previous report [23]. The performance of the assays was assessed by matching the data for
PRT, qPCR and Sequenom (Fig. 5; S2 Table). qPCR revealed a lower consistency with the two






The primer pair 38 distinguishes FCGR3A from FCGR3B while the primer pair 234 distinguishes the HNA1a
region from HNA1b.
doi:10.1371/journal.pone.0116791.t003
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assays (Fig. 5A—C); whereas the raw copy number call from Sequenom was in higher agree-
ment with PRT-REDVR (Fig. 5D). We observed that 78.2% of the copy number calls for
FCGR3B were in agreement between PRT-REDVR and Sequenom; while qPCR showed a
lower concordance rate with PRT-REDVR (60.1%) and Sequenom (75.4%) (Table 4; S2 Table).
The discordance increased with the increase of copy number calls. The concordance rate for all
the three assays though, has been relatively poor (57.3%). This observation agrees with the re-
port from the previous study [23]. CNV typing was repeated on the 10 of the discrepant sam-
ples by qPCR and PRT- REDVR and showed that six of these samples the discrepant
measurements are reproducible. We speculate that this could be due to small repeat specific
Figure 1. Distribution of raw unrounded copy number estimates of FCGR3A. A, Analysis was carried out
using 160 samples genotyped with Sequenom. Unrounded copy number estimates are in bins of 0.1, with the
count of each bin displayed on the y-axis. Blue indicates samples that were called as duplications, and red
samples that were called as deletions. The red bars indicate copy number loss (CN<2); black bars indicate
copy number normal (CN = 2); blue bars indicate copy number gain (CN>3). B, Distribution frequency of
absolute copy number call for the samples genotyped with SequenomMassARRAY and PRT-REDVR shows
a higher rate of copy number normal (CN = 2) being called by Sequenom.
doi:10.1371/journal.pone.0116791.g001
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deletions, or perhaps reflect single nucleotide variation underneath oligonucleotide primers
that reduce or abolish amplification from one repeat [13].
Collectively, our analyses strongly suggest that, i) the higher copy number, the greater dis-
crepancy in CNV estimation between assays; and ii) neither Sequenom nor qPCR assay is suit-
able for multi-allelic copy number variation genotyping.
To assess the quality of the copy number calls from PRT, we showed that both FAM- and
HEX-labelled PRT duplicates were highly correlated, except for one outlier (Fig. 6). Although
the clusters overlap, final copy number calls are made using information both from the PRT
Figure 2. Scatterplot showing 160matched samples for FCGR3ACNV estimated by PRT-REDVR and
Sequenom. Sequenom values represent raw copy number, PRT-REDVR values represent integer copy
numbers. Each point indicates sample being called by both Sequenom and PRT-REDVR. The blue line
indicates the trendline, suggesting an general concordance of the two platforms.
doi:10.1371/journal.pone.0116791.g002
Figure 3. Distribution frequency of absolute copy number call of FCGR3B for the samples genotyped
with all three different assays respectively. Analysis was carried out with 80 samples genotyped with
PRT-REDVR, Sequenom and qPCR. Loss, copy number< 2; normal, copy number = 2; gain, copy number
> 2.
doi:10.1371/journal.pone.0116791.g003
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data and the two REDVR assays. The raw Sequenom data (logEC50) generated from the three
distinct probes did correlate well with each other, but was slightly affected by the distance be-
tween probes especially with the highly copy number variable FCGR3B (Fig. 7). However the
advantages of having three probes outweighs the disadvantages. Another potential drawback of
the Sequenom assay is the batch effect observed (Fig. 7), which indicates that large changes in
absolute copy number can be generated by batch effect alone, although comparison with the
control probes may reduce this effect in the relative copy number estimates.
PRT is a PCR-based assay using a single pair of primers to simultaneously amplify two spe-
cific products in a single reaction: one from a single-copy reference locus and the other from
the copy variable test locus of interest–in this case, the FCGR3 region. The copy number of the
test locus is then estimated from the ratio of test to reference PCR products.
PRT relies on co-amplification of the test and reference locus using the same primer pair,
with test and reference distinguished by a small deletion, subsequently differentiated and quan-
tified using capillary electrophoresis. The primer pairs were designed in such a way that that it
amplifies a unique reference locus on chromosome 18 [13]. The test and reference PCR prod-
ucts can be distinguished by a small difference in size [13]. One limitation of this PRT assay is
that its development requires the presence of paralogue DNA sequence in the CNV regions to
allow comparison of ratio between reference and test locus, which at times not applicable to
many CNV loci. In addition, it only amplifies copies of a generic FCGR3, owing to the fact that
this region shows up to 98.3% sequence homology, posing a challenge in designing primers
specific for FCGR3A and FCGR3B CNV genotyping. Therefore, a multiplex REDVR assay was
used to amplify across the nucleotide which changed an arginine in FCGR3A to a stop codon
in FCGR3B, and a nucleotide that distinguished HNA1a from HNA1b. The a/b variant can be
Figure 4. Distribution of unrounded copy numbers called by qPCR and Sequenom for FCGR3B. Analysis was carried out using 100 samples
genotyped with both qPCR and Sequenom. Unrounded copy number estimates are in bins of 0.1, with the count of each bin displayed on the y-axis.
doi:10.1371/journal.pone.0116791.g004
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distinguished by digestion using TaqαI. The ratio of 3A:3B and HNA1a:HNA1b also provides
extra information on copy number helping distinguish copy numbers.
In both PRT and REDVR, inter-experiment calibration was corrected by running known
controls showing high agreement for total copy number between methods. This highlights the
advantage of this assay whereby it generates more reliable integer copy number calls with
inter-validation whilst easing the interpretation.
Figure 5. Scatterplot showing all 99 samples matched for FCGR3BCNVwith PRT-REDVR, Sequenom and qPCR. A. qPCR vs Sequenom. qPCR
values represent raw copy number, Sequenom values represent absolute copy numbers,B. Sequenom vs qPCR. Both Sequenom and qPCR raw copy
number values are presented, showing a low concordance rate between the two platforms,C. qPCR vs PRT-REDVR. qPCR values represent raw
unrounded copy number, PRT-REDVR values represent absolute copy number; andD. Sequenom vs PRT-REDVR. Sequenom values represent raw
unrounded copy numbers, PRT-REDVR values represent absolute copy number. The broader scater plots of qPCR signal intensity show wider variability of
copy number calls, suggesting more copy number calls from qPCRwere discordant with the Sequenom and PRT-REDVR. D exhibits a more clustered plot
indicating higher agreement of CN calls between Sequenom and PRT.
doi:10.1371/journal.pone.0116791.g005
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Our study suggests that qPCR could potentially introduce false-positive calls, therefore
CNV association studies based on qPCR should be counter validated. Indeed, many studies
showed contradictory findings on copy number and association with disease development, for
instance CCL3L1 in HIV [24], and DEFB4 in Crohn’s disease [19, 25]. The disadvantage of
qPCR though is common across copy number assays and this is expected in view of the princi-
ple of CNV and the chemistry of qPCR amplification. The absolute values also vary usually
upon repetition since qPCR is technically demanding. This again is a common phenomenon
observed in most qPCR assays [26].
Reports of CNV genotyping based on Sequenom have been relatively lacking. However,
more conservative calls in this assay potentially dilute true positive calls of CNV.
In summary, we suggest that qPCR assay is not suitable for the use in large scale case-con-
trol association studies for multi-allelic genes like FCGR3. On the other hand, PRT-REDVR
presents a relatively more reliable result as compared to both qPCR and SequenomMassAR-
RAY [24]. The sequence requirements for PRT assay development mean that it is limited to
certain sequences, and an assay cannot necessarily be designed for a small sequence region, for
example, one specific exon. However, the precision and accuracy of PRT-REDVR are equiva-
lent to those of MLPA and MAPH, and it has the advantage of potential high-throughput
analysis with the small amount of DNA required as of PCR-based methods [27]. Advantages
further include the robustness of assay, small amount of DNA, though potentially
introducing false negative result, running cost, and feasibility of equipment. The DNA integrity
though is a major determining factor for the specificity and robustness of an assay. Indepen-
dent assay such as microsatellite therefore, should warrant the informativeness of this
technology [13].
Figure 6. Analysis of raw copy number quantification data for PRT.Correlation between individual
duplicated PRT copy number. Individual results from FAM-labelled (Y-axis) versus Hex-labelled (X-axis)
representing internal replication of the assay, are plotted for 99 samples. Colour coded according to the
integer copy number of each samples as estimated in REDVR.
doi:10.1371/journal.pone.0116791.g006
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Supporting Information
S1 Table. Unrounded and absolute copy number calls for FCGR3A from Sequenom and
PRT-REDVR.
(XLSX)
S2 Table. Unrounded and absolute copy number calls for FCGR3B from qPCR, Sequenom
and PRT-REDVR.
(XLSX)
Figure 7. Analysis of raw quantification data (logEC50) for SequenomMassARRAY. Correlation between raw individual copy number calls from the
probes designed at 50-, 3’-, and centre regions of the genes FCGR3A (A, B, and C) and FCGR3B (D, E, and F). Note that there is a clear seperation of 2
cluster plots indicating batch effects, as circled, due to different experimental batches.A, 3’ vs 50; B, 3’ vs centre; andC, 50 vs centre; D, 50 vs 3’; E, 3’ vs
centre; and F, 50 vs centre. A and D, correlation between the 5- and 3- prime probes were slightly affected, probably due to the probes distance.
doi:10.1371/journal.pone.0116791.g007
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